Inhibition of G1P3 expression found in the differential display study on respiratory syncytial virus infection
Virology Journal volume 5, Article number: 114 (2008)
Respiratory syncytial virus (RSV) is the leading viral pathogen associated with bronchiolitis and lower respiratory tract disease in infants and young children worldwide. The respiratory epithelium is the primary initiator of pulmonary inflammation in RSV infections, which cause significant perturbations of global gene expression controlling multiple cellular processes. In this study, differential display reverse transcription polymerase chain reaction amplification was performed to examine mRNA expression in a human alveolar cell line (SPC-A1) infected with RSV.
Of the 2,500 interpretable bands on denaturing polyacrylamide gels, 40 (1.6%) cDNA bands were differentially regulated by RSV, in which 28 (70%) appeared to be upregulated and another 12 (30%) appeared to be downregulated. Forty of the expressed sequence tags (EST) were isolated, and 20 matched homologs in GenBank. RSV infection upregulated the mRNA expression of chemokines CC and CXC and interfered with type α/β interferon-inducible gene expression by upregulation of MG11 and downregulation of G1P3.
RSV replication could induce widespread changes in gene expression including both positive and negative regulation and play a different role in the down-regulation of IFN-α and up-regulation of IFN-γ inducible gene expression, which suggests that RSV interferes with the innate antiviral response of epithelial cells by multiple mechanisms.
Respiratory syncytial virus (RSV), a leading cause of epidemic respiratory tract infection in infants, spreads primarily by contact with contaminated secretions and replicates in the nasopharyngeal epithelium [1, 2]. The respiratory epithelium is postulated to be a primary initiator of pulmonary inflammation in patients with RSV infections . In general, to establish an infection in host cells successfully, viral entry to host cells results in two sets of events: activation of intracellular signaling pathways to regulate pathogenic gene expression [4, 5] and subversion of the host's innate immune response [6, 7]. RSV infection does not affect the expression of genes belonging to a single biological pathway but causes significant perturbation of global gene expression controlling multiple cellular processes . RSV replication also induces widespread changes in gene expression for cell-surface receptors, chemokines and cytokines, transcription factors, and cell signal transduction elements [8–10].
One pathway to upregulate chemokine gene expression was identified by the activation of mitogen-activated protein kinase and nuclear factor κB during RSV infection [11, 12]. The latter signaling cascade cluster includes chemokines, transcriptional regulators, intracellular proteins regulating translation and proteolysis, and secreted proteins [4, 9, 13], which influence the onset and severity of asthma. For the successful establishment of infection, RSV has also evolved several strategies to escape host cell antiviral mechanisms. Nonstructural proteins 1 and 2 cooperatively antagonize the antiviral effects of type I interferon (IFN) [14–16]. The G glycoprotein functions as a mimic of the CX3C chemokine , and during replication RSV displays a conformationally altered mature envelope that is less susceptible to an anti-F glycoprotein neutralizing antibody response . RSV infection inhibits IFN-α/β signaling by specific suppression of signal transducer and activator of transcription (STAT) 1/2 phosphorylation and the degradation of STAT2 expression, providing a molecular mechanism for viral evasion of host innate immune response [6, 19, 20]. Thus, RSV infection appears to cause widespread changes in gene expression, and multiple mechanisms are involved in the host innate immune response. Here we analyzed the early response of epithelium to RSV infection using differential display (DD) polymerase chain reaction (PCR) amplification of mRNA. Forty DD expression sequence tags (ESTs) were analyzed, and two IFN-inducible genes, G1P3 and MG11, were examined during RSV infection.
RSV induced mRNA differential display in SPC-A1 cells
To obtain the DD profile of SPC-1A cells in the presence or absence of RSV infection, total cellular RNA was extracted at 24 h after viral infection. Using an oligo-(dT) primer with A, C or G at the 3'-terminal position and one of 24 arbitrary primers, 72 PCR reactions were performed and produced c.2, 500 interpretable bands on denaturing polyacrylamide gels. Each primer pair combination PCR reaction was run twice. Of the 2,500 bands surveyed, 40 (1.6%) were differentially regulated by RSV infection and were excised for further investigation. The criteria for defining such a DD band have been described [21, 22]: differential display cDNAs modulated by RSV needed to show pronounced differences between treatment groups, consistency between two reactions, overall band intensity, and a size of 50–600 nt. In this subjective assessment, 15 DD cDNAs were the most intense, demonstrating extreme differentiation between treatment groups ("on" vs "off" signals); 18 were intense with modest differentiation and seven were less intense, but showed extreme differentiation between treatment groups. Of these 40 excised cDNA bands, 28 (70%) appeared to be upregulated by RSV infection and another 12 (30%) appeared to be downregulated.
Characterization of differential display bands
These DD cDNAs were successfully reamplified, sequenced, and identified by BLAST searching http://www.ncbi.nlm.nih.gov/blast/. Sequences were compared by BLAST against GenBank http://www.ncbi.nlm.nih.gov/Genbank/ and dbEST http://www.ncbi.nlm.nih.gov/dbEST/ with the DD sequence identities established as the highest scoring annotated cDNA or EST sequences. Two ESTs appeared to encode repetitive elements and one was deleted from this DD profile. Thirty-four ESTs from these 40 sequences had been submitted to dbEST [GenBank: CB238796–CB238829]. Twenty-eight ESTs were upregulated by RSV infection and 12 were downregulated in the same samples. Among the twenty-eight upregulated ESTs group, 16 ESTs matched with known genes in GenBank, five matched with dbEST or hypothetical genes or predicted mRNAs without identified function, and seven were sequences with mismatches in either dbEST or GenBank (Table 1). In the downregulated group, four ESTs had homologs to known genes, four matched to dbEST with a definition of hypothetical genes or predicted mRNAs, and four sequences mismatched either in dbEST or GenBank (Table 2).
Classification of differential display mRNA functions
Among the 20 cloned ESTs, which were matched to their homologs in GenBank or dbETS, two were genes for the chemokines, CC (Hs.10458) and CXC (Hs. 82407), already confirmed to be associated with responses to RSV infection. Others were genes for the Ras-binding protein, zinc finger protein 265, membrane protein CD79A, metabolism flavoprotein, NADH dehydrogenase, phospholipase, and the IFN-γ-inducing factor MG11, which were all upregulated in SPC-A1 cells infected with RSV. Interestingly, RSV infection upregulated expression of the gene for MG11 but suppressed the gene for the IFN-α inducible protein G1P3. These results suggested that RSV replication could induce widespread changes in gene expression including both positive and negative regulation.
RSV upregulated MG11 and downregulated G1P3 mRNA expressions
To confirm that RSV replication interferes with G1P3 and MG11 mRNA expression in SPC-A1 cells, real-time PCR was performed to quantify mRNA levels after virus infection. To check G1P3 mRNA, SPC-A1 cells were infected with RSV at a multiplicity of infection (MOI) value of 3, and INF-a was added to the culture at final concentration of 1000 U/mL for 30 min. Total RNA was extracted at the indicated time points. RSV inhibited INF-a induced G1P3 expression time-dependently, while it induced MG11 mRNA expression: an IFN-g inducible gene (Fig.1 ). These results suggested that RSV infection plays a different role in the regulation of type a and type g IFN-induced gene expression (Fig. 2).
Differential display is a semiquantitative, RT-PCR based technique that is used to compare mRNAs from two or more conditions of interest . It is usually used to search for specific gene expression patterns associated with diseases and to find novel genes . We tested for differential gene expression in SPC-A1 cells challenged with RSV infection. Our aim was to find novel transcripts modulated by RSV in the early stage of infection. We isolated 40 DD ESTs: 1.6% of c. 2500 bands identified. Sixteen were upregulated and four were downregulated following infection, and these were matched with homologous mRNAs in GenBank. They included IFN-inducible genes and genes for chemokines, membrane molecules, and metabolic factors.
Severe RSV infections involving the lower respiratory tract are primarily seen in young children with naive immune systems or genetic predispositions [1, 2]. RSV replication is restricted to airway epithelial cells, where RSV replication induces potent expression of chemokines, so the epithelium is postulated to be a primary initiator of pulmonary inflammation in RSV infections . The presence of eosinophil cationic protein and histamine are correlated with disease severity in the pathology of RSV infections. Here we also found that both chemokines CC and CXC were upregulated during RSV infection in SPC-A1 cells. The mechanisms responsible for recruitment of circulating leukocytes, mononuclear cells, and lymphocytes into the lung because of RSV infection are largely attributed to chemokines [5, 23, 24]. These are a superfamily of small chemotactic cytokines, which regulate the migration and activation of leukocytes and play a key role in inflammatory and infectious processes of the lung [25, 26]. They are divided into functionally distinct groups: three groups of small basic (heparin-binding) proteins, termed the C, CC, and CXC chemokines (based on the number and spacing of highly conserved NH2-terminal cysteine residues), and a fourth, distantly related group, the CX3C chemokines, composed of large, membrane-bound glycoproteins attached through a COOH-mucin-like domain.
Other DD mRNAs of interest were for the IFN-induced genes G1P3 and MG11. G1P3, an interferon-stimulated gene (ISG) with a length of 829 bp , belongs to the FAM14 family of proteins and has an approximate molecular weight of 13–14 kDa. It has been identified that ectopically expressed G1P3 localized to mitochondria and antagonized TRAIL-mediated mitochondrial potential loss, cytochrome c release, and apoptosis, which contributed the specificity of G1P3 for the intrinsic apoptosis pathway by the direct role of a mitochondria-localized prosurvival ISG in antagonizing the effect of TRAIL. Furthermore, downregulation of G1P3 restored IFN-α2b-induced apoptosis. Curtailing G1P3-mediated anti-apoptotic signals could improve therapies for myeloma or other malignancies. G1P3 was potently induced by IFN-α2b not only myeloma cell lines but also in fresh myeloma cells and resistant to chemotherapy-induced apoptosis. Unlike in cancer cells, the antiapoptotic activity of G1P3 may have a beneficial effect on IFN-mediated antiviral and innate immune responses. During viral infection, delaying early apoptosis through survival factor induction would be a viable cellular strategy to protect surrounding healthy cells from viral infection, enhancing IFN secretion, and overcoming proapoptotic activity of cytokines released into the surrounding milieu. In vitro experiments, the type I IFNs (α/β) induce transcription while type II interferon is a poor inducer of transcription for this gene . IFN-α effectively inhibits hepatitis C virus subgenomic RNA replication and suppresses viral nonstructural protein synthesis. G1P3 enhances IFN-α antiviral efficacy by the activation of STAT3-signaling pathway and intracellular gene activation [30, 31]. However, in our experiments, RSV infection appeared to inhibit IFN-α induced G1P3 mRNA, which suggested that virus escaped innate surveillance by subverting IFN-mediated antiviral response.
MG11, encoding a 56-kD protein, was found first in cultured astrocytes stimulated with IFN-γ. There is no evidence to identify this protein's function in host cell antiviral responses .
Our results show RSV replication could induce widespread changes in gene expression including both positive and negative regulation and play a different role in the down-regulation of type α and up-regulation of type γIFN-induced gene expression, which suggests that RSV interferes with the innate antiviral response of epithelial cells by multiple mechanisms.
Virus and cells
The human Long strain of RSV (ATCC, Manassas, VA, USA) was propagated in monolayers of Hep-2 cells grown in Eagle's minimum essential medium Gibco, NY, USA) supplemented with 10% heat-inactivated fetal bovine serum (FBS). At maximum cytopathic effect, the cells were harvested and disrupted by sonication in the same culture medium. The suspension was clarified by centrifugation at 8,000 g for 10 min at 4°C and the supernatant was layered on top of a sucrose cushion (30% sucrose in 50 mM Tris buffered-normal saline solution containing 1 mM ethylenediaminetetraacetate [EDTA], pH 7. 5), and further centrifuged at 100,000 g for 1 h at 4°C. Pellets containing virus were resuspended in 10 mM phosphate buffered saline containing 15% sucrose and stored in aliquots at -80°C.
SPC-A1 cells (Human typeIIalveolar cell line) were obtained from China Type Culture Collection (CCTCC, Wuhan University, China) and cultured in Dulbecco's Modified Eagle's Medium (DMEM; Life Technologies Gibco BRL, Gaithersburg, MD, USA) supplemented with 10% FBS, 2 mM glutamine, penicillin (100 U/mL), and streptomycin (100 μg/mL) at 37°C under 5% CO2 [32, 33]. For viral infection, 80% confluent cells were inoculated with RSV at a MIO value of 3. An equivalent amount of sucrose solution was added to the control culture (which received no RSV). The flasks were rocked mechanically for 1 h at 37°C, and then supplemented with 2% FBS+DMEM and incubated at 37°C under 5% CO2. To test interferon (IFN)-α inducible gene expression, SPC-A1 cells were infected with RSV at moi 1, and IFN-α (PBL Biomedical Laboratories, Piscataway, NJ, USA) was added to cultures at the indicated times for 30 min to a final concentration of 1000 U/mL.
Differential display RT-PCR
Differential display RT-PCR was performed as described [21, 22]. In brief, cDNA was synthesized from total RNA isolated from SPC-A1 cells using 250 ng 3'-anchored oligo-(dT) 10 μM primers, 3 μg total RNA, 1 μl 10 mM dNTP, 4 μl 5 × First-Strand Buffer, 2 μL 0.1 M DTT, 1 μL ribonuclease inhibitor RNaseOUT (40 U/μL), and 1 μL (200 U) of M-MLV Reverse Transcriptase (Invitrogen Life Technologies, Carlsbad, CA, USA), according to the manufacturer's protocol. cDNA was treated with RNase-free DNase to remove any contaminating genomic DNA. RT-PCR was run with the anchoring primers and one of the 24 random 10-mer primers supplied in the same kit. Amplifications were run for 40 cycles with denaturation at 94°C for 30 sec, annealing at 45°C for 45 sec, and elongation at 72°C for 45 sec with a 10 min extension at 72°C after the last cycle.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
After addition of a denaturing loading dye (95% formamide, 0.05% bromophenol blue 0.05% xylene cyanol) and a 2 min, 95°C heat step, PCR products were electrophoresed on 6% denaturing sodium dodecyl sulfate polyacrylamide gels, and developed with 0.1% silver stained according to the protocols of Silver Sequence™ (Promega, Madison, WI, USA) for development and visualization.
Excision, reamplification, and identification of DD products
Bands that appeared to be differential display were excised from the gels and eluted into 100 μL TE buffer (10 mM Tris/1 mM EDTA) by boiling for 10 min. The eluted DNA samples were then used as templates for PCR reamplification: 1 μL of DD-products were used in a 25 μL PCR reaction containing 2.5 μL of 10 × PCR buffer, 2.5 μL of 10 mM dNTPs, 1 μL of 30 μM downstream primer, 1 μL of 30 μM upstream primer, and 0.5 μL of Taq polymerase(Invitrogen Life Technologies, Carlsbad, CA, USA). Cycling conditions were identical to those used for RT-PCR. Reamplified PCR products were electrophoresed on 2% agarose gels, stained with ethidium bromide, excision, and purified with a DNA purification column(E.Z.N.A. TM Ploy Gel DNA Extraction Kit, Omega Bio-Tek, Inc. USA).
cDNA cloning and sequencing
Differentially expressed cDNA amplicons were subcloned into the pGEM T easy vector ((Promega, Madison, WI, USA) and sequenced using the DYEnamic ET terminator cycle sequencing kit (Amersham Pharmacia Biotech Limited, UK). Sequencing reactions included 0.1 pmol DNA template, 5 pmol universal upstream primer, and 8 μL reagent premix at final volume of 20 μL. Labeling was carried out at 95°C for 20 sec, 50°C for 15 sec, and 60°C for 1 min, for 30 cycles and sequencing was carried out using an ABI PRISM 3100 (Applied Biosystems, Foster City, CA, USA).
Real-time PCR reactions were performed using the protocol of ABI (Applied Biosystems, Foster City, CA, USA). The primer sets were designed for G1P3 (NM_022872), forward: 5'-CCTCGCTGATGAGCTGGTCT-3', reverse: 5'-CTATCGAGATACTTGTGGGTGGC-3', and for MG11 (AK027811), forward: 5'-CTGGAACTCCATCCCGACTA-3', reverse: 5'-GGCAGTAATGCGCCTGTGA-3'. Quantification of cDNA targets was performed using an ABI Prism® 7000HT Sequence Detection System (Applied Biosystems), using SDS version 2.1 software. Each reaction contained 10 μL SYBR Green I Master Mix, 1 μL 30 nM forward and reverse primers, and 25 ng cDNA diluted in 9 μL RNase-free water. Thermal cycler conditions were run for 10 min at 95°C, then 40 cycles of 15 sec at 95°C and 1 min at 60°C per cycle using the ABI Prism® 7000 Sequence Detection System (Applied Biosystems). All reactions were run in duplicates, and data were normalized to glyceraldehyde-3-phosphate dehydrogenase as an internal control. Real-time PCR data were analyzed using the standard curve method.
BLAST searching in GenBank and dbEST
Differential display cDNA ESTs were matched in GenBank BLASTN and dbEST. Searches against dbEST were performed to analyze for the abundance of transcripts, to obtain information on possible specificity of mRNA expression, and to identify putative alternative splice forms. Sequences were edited manually by using Sequencher (version 4.14; http://www.genecodes.com/sequencher/) to remove vector sequences and to identify trash sequences, defined as sequences from bacterial DNA, sequences from primer polymers or sequences containing > 5% of ambiguous bases.
Respiratory syncytial virus
Differential display reverse transcription polymerase chain reaction
Expression sequence tags.
Hall CB, Douglas RG, Schnabel KC, Geiman JM: Infectivity of respiratory syncytial virus by various routes of inoculation. Infect Immun 1981, 33: 779-783.
Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B: Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med 2000, 161: 1501-1507.
Martin LD, Rochelle LG, Fischer BM, Krunkosky TM, Adler KB: Airway epithelium as an effector of inflammation: molecular regulation of secondary mediators. Eur Respir J 1997, 10: 2139-2146. 10.1183/09031936.97.10092139
Olszewska-Pazdrak B, Casola A, Saito T, Alam R, Crowe SE, Mei F, Ogra PL, Garofalo RP: Cell-specific expression of RANTES, MCP-1, and MIP-1α by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol 1998, 72: 4756-4764.
Zhang YH, Luxon BA, Casola A, Garofalo RP, Jamaluddin M, Brasier AR: Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J Virol 2001, 75: 9044-9058. 10.1128/JVI.75.19.9044-9058.2001
Ramaswamy M, Shi L, Monick MM, Hunninghake GW, Look DC: Specific inhibition of Type I interferon signal transduction by respiratory syncytial virus. Am J Respir Cell Mol Biol 2004,30(6):893-900. 10.1165/rcmb.2003-0410OC
Gotoh B, Komatsu T, Takeuchi K, Yokoo J: Paramyxovirus accessory proteins as interferon antagonists. Microbiol Immunol 2001, 45: 787-800.
Domachowske JB, Bonville CA, Rosenberg HF: Gene expression in epithelial cells in response to pneumovirus infection. Respir Res 2001, 2: 225-233. 10.1186/rr61
Garofalo R, Sabry M, Jamaluddin M, Yu RK, Casola A, Ogra PL, Brasier AR: Transcriptional activation of the interleukin-8 gene by RSV infection in alveolar epithelial cells: nuclear translocation of the RelA transcription factor as a mechanism producing airway mucosal inflammation. J Virol 1996, 70: 8773-8781.
Kong XY, Juana HS, Behera A, Peeples ME, Wu J, Lockeya RF, Mohapatra SS: ERK-1/2 activity is required for efficient RSV infection. FEBS Letters 2004, 559: 33-38. 10.1016/S0014-5793(04)00002-X
Pazdrak K, Olszewska-Pazdrak B, Liu T, Takizawa R, Brasier AR, Garofalo RP, Casola A: MAPK activation is involved in posttranscriptional regulation of RSV-induced RANTES gene expression. Am J Physiol Lung Cell Mol Physiol 2002,283(2):L364-L372.
Tian B, Zhang Y, Luxon BA, Garofalo RP, Casola A, Sinha M, Brasier AR: Identification of NF-κB-dependent gene networks in respiratory syncytial virus-infected cells. J Virol 2002, 76: 6800-6814. 10.1128/JVI.76.13.6800-6814.2002
Fiedler MA, Wernke-Dollries K, Stark JM: Respiratory syncytial virus increases IL-8 gene expression and protein release in A549 cells. Am J Physiol 1995,269(6 Pt 1):L865-L872.
Spann KM, Tran KC, Chi B, Rabin RL, Collins PL: Suppression of the induction of alpha, beta, and lambda interferons by the NS1 and NS2 proteins of human respiratory syncytial virus in human epithelial cells and macrophages. J Virol 2004, 78: 4363-4369. 10.1128/JVI.78.8.4363-4369.2004
Bossert B, Marozin S, Conzelmann KK: Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3. J Virol 2003, 77: 8661-8668. 10.1128/JVI.77.16.8661-8668.2003
Schlender J, Bossert B, Buchholz U, Conzelmann KK: Bovine respiratory syncytial virus nonstructural proteins NS1 and NS2 cooperatively antagonize alpha/beta interferon-induced antiviral response. J Virol 2000, 74: 8234-8242. 10.1128/JVI.74.18.8234-8242.2000
Tripp RA: The brume surrounding respiratory syncytial virus persistence. Am J Respir Crit Care Med 2004, 169: 778-779. 10.1164/rccm.2401013
Sakurai H, Williamson RA, Crowe JE, Beeler JA, Poignard P, Bastidas RB, Chanock RM, Burton DR: Human antibody responses to mature and immature forms of viral envelope in respiratory syncytial virus infection: significance for subunit vaccines. J Virol 1999, 73: 2956-2962.
Lo MS, Brazas RM, Holtzman MJ: Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 expression and alpha/beta interferon responsiveness. J Virol 2005, 79: 9315-9319. 10.1128/JVI.79.14.9315-9319.2005
Zhang WD, Yang H, Kong X, Mohapatra S, Juan-Vergara HS, Hellermann G, Behera S, Singam R, Lockey RF, Mohapatra SS: Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med 2005, 11: 56-62. 10.1038/nm1174
Moore JB, Blanchard RK, Cousins RJ: Dietary zinc modulates gene expression in murine thymus: Results from a comprehensive differential display screening. PNAS 2003, 100: 3883-3888. 10.1073/pnas.0330670100
Vinogradava T, Leppik L, Kalinina E, Zhulidov P, Grzschik KH, Sverdlov E: Selective differential display of RNAs containing interspersed repeats: analysis of changes in the transcription of HERV-K LTRs in germ cell tumors. Mol Genet Genomics 2002, 266: 796-805. 10.1007/s00438-001-0596-7
Konrad P, Barbara OP, Liu T, Takizawa R, Brasier AR, Garofalo RP, Casola A: MAPK activation is involved in posttranscriptional regulation of RSV induced RANTES gene expression. Am J Physiol Lung Cell Mol Physiol 2002,283(2):L364-L372.
Barbara OP, Casola A, Saito T, Alam R, Crowe SE, Mei F, Ogra P, Garofalo RP: Cell-specific expression of RANTES, MCP-1, and MIP-1a by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol 1998, 72: 4756-4764.
Cook DN, Beck MA, Coffman TM, Kirby SL, Sheridan JF, Pragnell IB, Smithies O: Requirement of MIP-1α for an inflammatory response to viral infection. Science 1995, 269: 1583-1585. 10.1126/science.7667639
Harrison AM, Bonville CA, Rosenberg HF, Domachowske JB: Respiratory syncytical virus-induced chemokine expression in the lower airways: eosinophil recruitment and degranulation. Am J Respir Crit Care Med 1999, 159: 1918-1924.
Friedman RL, Manly S, McMahon M, Kerr IM, Stark GR: Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells. Cell 1984, 38: 745-755. 10.1016/0092-8674(84)90270-8
Venugopalan C, Keith BG, Jeffrey FW, Rachid B, Mohamad AH, Ernest CB: G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells. Clin Invest 2007, 117: 3107-3117. 10.1172/JCI31122
Parker N, Porter AC: Identification of a novel gene family that includes the interferon-inducible human genes 6–16 and ISG12. BMC Genomics 2004,5(1):8. Doi: 10. 1186/1471-2164-5-8 10.1186/1471-2164-5-8
Bieche I, Asselah T, Laurendeau I, Vidaud D, Degot C, Paradis V, Bedoss P, Vall DC, Marcellin P, Vidaud M: Molecular profiling of early stage liver fibrosis in patients with chronic hepatitis C virus infection. Virology 2005, 332: 130-144. 10.1016/j.virol.2004.11.009
Zhu H, Zhao H, Collins CD, Eckenrode SE, Run Q, McIndoe RA, Crawford JM, Nelson DR, She JX, Liu C: Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 2003, 37: 1180-1188. 10.1053/jhep.2003.50184
Cuin KA, Porter AC: Characterisation of a novel minisatellite that provides multiple splice donor sites in an interferon-induced transcript MG. Nucleic Acids Res 1995, 23: 1854-1861. 10.1093/nar/23.11.1854
Dong QG, Gong LL, Wang HJ, Wang EZ: Isolation of a mitomycin-resistant human lung adenocarcinoma cell subline to investigate the modulation by sodium butyrate of cell growth and drug resistance. Anticancer Drugs 1993, 4: 617-27. 10.1097/00001813-199312000-00003
Li L, Zhao DC, Zhang CY, Zhang QW, You SY: Prokaryotic expression and polyclonal antibody preparation of novel ZLG10 protein involved in infection of RSV on SPC-A1 cells. Protein Expr Purif 2005, 41: 170-176. 10.1016/j.pep.2005.01.020
This work was supported by National Natural Science Foundation of China (30371501) and Hubei scientific project (2004AA301C25).
The authors declare that they have no competing interests.
DZ developed the study design, laboratory work, participated in data collection, analysis and manuscript writing. DP participated in data collection, laboratory work, data entry and manuscript writing. LL participated in study design, data collection, and laboratory work. QZ developed the data analysis plan and was responsible for data analysis. CZ developed the data analysis plan and manuscript writing. All authors read and approved the final manuscript.
About this article
Cite this article
Zhao, D., Peng, D., Li, L. et al. Inhibition of G1P3 expression found in the differential display study on respiratory syncytial virus infection. Virol J 5, 114 (2008). https://doi.org/10.1186/1743-422X-5-114